{"id":"https://openalex.org/W1961375326","doi":"https://doi.org/10.1111/jep.12422","title":"The impact of persistence with bisphosphonates on health resource utilization and fracture risk in the UK : a study of patient records from the UK C linical P ractice R esearch D atalink","display_name":"The impact of persistence with bisphosphonates on health resource utilization and fracture risk in the UK : a study of patient records from the UK C linical P ractice R esearch D atalink","publication_year":2015,"publication_date":"2015-08-16","ids":{"openalex":"https://openalex.org/W1961375326","doi":"https://doi.org/10.1111/jep.12422","mag":"1961375326","pmid":"https://pubmed.ncbi.nlm.nih.gov/26279458","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5042106"},"language":"en","primary_location":{"id":"doi:10.1111/jep.12422","doi":"https://doi.org/10.1111/jep.12422","is_oa":true,"landing_page_url":"https://doi.org/10.1111/jep.12422","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jep.12422","source":{"id":"https://openalex.org/S2713501","display_name":"Journal of Evaluation in Clinical Practice","issn_l":"1356-1294","issn":["1356-1294","1365-2753"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Evaluation in Clinical Practice","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jep.12422","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036912940","display_name":"Samara Ferguson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117596","display_name":"Amgen (United Kingdom)","ror":"https://ror.org/02gvvc992","country_code":"GB","type":"company","lineage":["https://openalex.org/I1320553840","https://openalex.org/I4210117596"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Samara Ferguson","raw_affiliation_strings":["United Kingdom Value, Access & Policy Amgen Ltd Cambridge UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"United Kingdom Value, Access & Policy Amgen Ltd Cambridge UK","institution_ids":["https://openalex.org/I4210117596"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089364956","display_name":"Maurille Feudjo Tepie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117596","display_name":"Amgen (United Kingdom)","ror":"https://ror.org/02gvvc992","country_code":"GB","type":"company","lineage":["https://openalex.org/I1320553840","https://openalex.org/I4210117596"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Maurille Feudjo Tepie","raw_affiliation_strings":["Center for Observational Research, Amgen Ltd., Uxbridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Observational Research, Amgen Ltd., Uxbridge, UK","institution_ids":["https://openalex.org/I4210117596"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Andrew Taylor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117596","display_name":"Amgen (United Kingdom)","ror":"https://ror.org/02gvvc992","country_code":"GB","type":"company","lineage":["https://openalex.org/I1320553840","https://openalex.org/I4210117596"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Andrew Taylor","raw_affiliation_strings":["Clinical Development Amgen Ltd Cambridge UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development Amgen Ltd Cambridge UK","institution_ids":["https://openalex.org/I4210117596"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056751707","display_name":"Andrew Roddam","orcid":"https://orcid.org/0000-0001-7378-7615","observed_orcids":["https://orcid.org/0000-0001-7378-7615"]},"institutions":[{"id":"https://openalex.org/I4210117596","display_name":"Amgen (United Kingdom)","ror":"https://ror.org/02gvvc992","country_code":"GB","type":"company","lineage":["https://openalex.org/I1320553840","https://openalex.org/I4210117596"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Andrew Roddam","raw_affiliation_strings":["Clinical Development, Amgen Ltd, Uxbridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development, Amgen Ltd, Uxbridge, UK","institution_ids":["https://openalex.org/I4210117596"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108390714","display_name":"Cathy W. Critchlow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cathy Critchlow","raw_affiliation_strings":["Center for Observational Research, Amgen, Inc., Thousand Oaks, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Observational Research, Amgen, Inc., Thousand Oaks, CA, USA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101492406","display_name":"Mazhar Iqbal","orcid":"https://orcid.org/0009-0005-3993-6687","observed_orcids":["https://orcid.org/0009-0005-3993-6687"]},"institutions":[{"id":"https://openalex.org/I4210117596","display_name":"Amgen (United Kingdom)","ror":"https://ror.org/02gvvc992","country_code":"GB","type":"company","lineage":["https://openalex.org/I1320553840","https://openalex.org/I4210117596"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mazhar Iqbal","raw_affiliation_strings":["Scientific Affairs, Amgen Ltd, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Scientific Affairs, Amgen Ltd, Cambridge, UK","institution_ids":["https://openalex.org/I4210117596"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007808322","display_name":"Leslie Spangler","orcid":"https://orcid.org/0000-0002-3207-5758","observed_orcids":["https://orcid.org/0000-0002-3207-5758"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leslie Spangler","raw_affiliation_strings":["Center for Observational Research, Amgen, Inc., Thousand Oaks, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Observational Research, Amgen, Inc., Thousand Oaks, CA, USA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078328291","display_name":"Jonathan Bayly","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I22128151","display_name":"University of Derby","ror":"https://ror.org/02yhrrk59","country_code":"GB","type":"education","lineage":["https://openalex.org/I22128151"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jonathan Bayly","raw_affiliation_strings":["Faculty of Education, Health and Sciences University of Derby Derby UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Education, Health and Sciences University of Derby Derby UK","institution_ids":["https://openalex.org/I22128151"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4430,"currency":"USD","value_usd":4430},"apc_paid":{"value":4430,"currency":"USD","value_usd":4430},"fwci":0.6232,"has_fulltext":true,"cited_by_count":7,"citation_normalized_percentile":{"value":0.69913206,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"22","issue":"1","first_page":"31","last_page":"39"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10071","display_name":"Bone health and osteoporosis research","score":0.9023000001907349,"subfield":{"id":"https://openalex.org/subfields/2732","display_name":"Orthopedics and Sports Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10071","display_name":"Bone health and osteoporosis research","score":0.9023000001907349,"subfield":{"id":"https://openalex.org/subfields/2732","display_name":"Orthopedics and Sports Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.052000001072883606,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.021400000900030136,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bisphosphonates","display_name":"bisphosphonates","score":0.9860000014305115},{"id":"https://openalex.org/keywords/medication-persistence","display_name":"treatment persistence","score":0.7459999918937683},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.8159999847412109},{"id":"https://openalex.org/keywords/health-resource-utilization","display_name":"health resource utilization","score":0.8659999966621399},{"id":"https://openalex.org/keywords/fracture-risk","display_name":"fracture risk","score":0.9539999961853027},{"id":"https://openalex.org/keywords/osteoporosis","display_name":"osteoporosis","score":0.9559999704360962},{"id":"https://openalex.org/keywords/postmenopausal-women","display_name":"postmenopausal women","score":0.8830000162124634},{"id":"https://openalex.org/keywords/long-term-treatment","display_name":"long-term treatment","score":0.40700000524520874},{"id":"https://openalex.org/keywords/real-world-evidence","display_name":"real-world evidence","score":0.5540000200271606}],"concepts":[{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.9011696577072144},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8266904950141907},{"id":"https://openalex.org/C2781009140","wikidata":"https://www.wikidata.org/wiki/Q7170389","display_name":"Persistence (discontinuity)","level":2,"score":0.676207423210144},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.5775099992752075},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4937938153743744},{"id":"https://openalex.org/C2777251235","wikidata":"https://www.wikidata.org/wiki/Q412205","display_name":"Bisphosphonate","level":3,"score":0.42489689588546753},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.34842145442962646},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3372417092323303},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32494544982910156},{"id":"https://openalex.org/C2776541429","wikidata":"https://www.wikidata.org/wiki/Q165328","display_name":"Osteoporosis","level":2,"score":0.23686236143112183},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.06506484746932983},{"id":"https://openalex.org/C187320778","wikidata":"https://www.wikidata.org/wiki/Q1349130","display_name":"Geotechnical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004164","descriptor_name":"Diphosphonates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006113","descriptor_name":"United Kingdom","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D006295","descriptor_name":"Health Resources","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008485","descriptor_name":"Medical Audit","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015663","descriptor_name":"Osteoporosis, Postmenopausal","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050071","descriptor_name":"Bone Density Conservation Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D050723","descriptor_name":"Fractures, Bone","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D050723","descriptor_name":"Fractures, Bone","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/jep.12422","doi":"https://doi.org/10.1111/jep.12422","is_oa":true,"landing_page_url":"https://doi.org/10.1111/jep.12422","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jep.12422","source":{"id":"https://openalex.org/S2713501","display_name":"Journal of Evaluation in Clinical Practice","issn_l":"1356-1294","issn":["1356-1294","1365-2753"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Evaluation in Clinical Practice","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5042106","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5042106","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Eval Clin Pract","raw_type":"Text"},{"id":"pmid:26279458","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26279458","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of evaluation in clinical practice","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/jep.12422","doi":"https://doi.org/10.1111/jep.12422","is_oa":true,"landing_page_url":"https://doi.org/10.1111/jep.12422","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jep.12422","source":{"id":"https://openalex.org/S2713501","display_name":"Journal of Evaluation in Clinical Practice","issn_l":"1356-1294","issn":["1356-1294","1365-2753"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Evaluation in Clinical Practice","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1961375326.pdf","grobid_xml":"https://content.openalex.org/works/W1961375326.grobid-xml"},"referenced_works_count":37,"referenced_works":["https://openalex.org/W1526826623","https://openalex.org/W1562584460","https://openalex.org/W1823423766","https://openalex.org/W1963491484","https://openalex.org/W1970782797","https://openalex.org/W1984754135","https://openalex.org/W1990771263","https://openalex.org/W1993035292","https://openalex.org/W2002978740","https://openalex.org/W2008055393","https://openalex.org/W2017797540","https://openalex.org/W2018401691","https://openalex.org/W2031400196","https://openalex.org/W2040492681","https://openalex.org/W2065505598","https://openalex.org/W2090650934","https://openalex.org/W2099054178","https://openalex.org/W2102123887","https://openalex.org/W2107177524","https://openalex.org/W2107494198","https://openalex.org/W2107889225","https://openalex.org/W2108063837","https://openalex.org/W2118100789","https://openalex.org/W2124527463","https://openalex.org/W2125805655","https://openalex.org/W2128778774","https://openalex.org/W2150539152","https://openalex.org/W2153009489","https://openalex.org/W2157979607","https://openalex.org/W2161837912","https://openalex.org/W2162444993","https://openalex.org/W2163589808","https://openalex.org/W2163830908","https://openalex.org/W2185954894","https://openalex.org/W2321227665","https://openalex.org/W2904877638","https://openalex.org/W3135185800"],"related_works":["https://openalex.org/W2060107533","https://openalex.org/W2997999335","https://openalex.org/W2104991259","https://openalex.org/W1976796217","https://openalex.org/W7132645078","https://openalex.org/W2283977833","https://openalex.org/W3003305559","https://openalex.org/W2007233990","https://openalex.org/W1984754135","https://openalex.org/W2157979607"],"abstract_inverted_index":{"RATIONALE,":[0],"AIMS":[1],"AND":[2],"OBJECTIVES:":[3],"Clinical":[4,60],"trial":[5],"data":[6,22,56],"suggest":[7],"that":[8,149,228,248],"patients":[9,96,105,132,143,173,233,253],"who":[10,47,97,106],"have":[11],"received":[12],"bisphosphonates":[13,213],"continue":[14],"to":[15,199,219,225],"benefit":[16],"from":[17,23,57,201],"them":[18],"after":[19,214],"discontinuation.":[20],"However,":[21],"real-world":[24],"clinical":[25,202],"practice":[26],"are":[27],"inconclusive.":[28],"We":[29],"assessed":[30],"the":[31,58,208,226,239,246],"impact":[32],"of":[33,74,117,191,211,241],"persistence":[34,102,113,158,163,175],"and":[35,42,81,93,104,126,151,222,254],"discontinuation":[36,215,243],"on":[37,236,251],"health":[38,255],"resource":[39],"utilization":[40],"(HRU)":[41],"fracture":[43,92,128,152,192,223],"rate":[44,89,129,240],"in":[45,156,161,174,204],"women":[46],"were":[48,84,136,144,154,193],"prescribed":[49],"oral":[50,75,212],"bisphosphonates.":[51],"METHOD:":[52],"The":[53,115],"study":[54],"used":[55],"UK":[59],"Practice":[61],"Research":[62],"Datalink.":[63],"Women":[64],"aged":[65],"50":[66],"years":[67],"or":[68],"older":[69],"with":[70,124,127],"a":[71],"first":[72],"prescription":[73],"bisphosphonate":[76],"therapy":[77],"between":[78,95],"January":[79],"2000":[80],"December":[82],"2007":[83],"included.":[85,145],"Multivariate":[86],"modelling":[87],"compared":[88],"ratios":[90],"for":[91,110,130,181],"HRU":[94,125,150,178,221],"had":[98,234],"discontinued":[99],"medication":[100,109],"(shorter":[101],"group)":[103],"took":[107],"their":[108],"longer":[111,157],"(longer":[112],"group).":[114],"interactions":[116],"elapsed":[118],"time":[119],"(measured":[120],"as":[121],"6-month":[122,167],"intervals)":[123],"all":[131,172],"within":[133],"paired":[134],"groups":[135,159],"also":[137,194],"assessed.":[138],"RESULTS:":[139],"Overall,":[140],"36":[141],"320":[142],"Pairwise":[146],"comparisons":[147],"showed":[148,169],"rates":[153,224],"lower":[155],"than":[160],"shorter":[162],"groups.":[164],"Analysis":[165],"by":[166],"interval":[168],"that,":[170],"across":[171],"group":[176],"pairs,":[177],"significantly":[179],"increased":[180,189],"each":[182],"additional":[183],"6":[184],"months":[185],"elapsed;":[186],"trends":[187],"towards":[188],"risk":[190],"seen.":[195],"CONCLUSION:":[196],"In":[197],"contrast":[198],"results":[200],"trials,":[203],"this":[205],"patient":[206],"population":[207],"protective":[209],"effect":[210],"was":[216],"not":[217],"sufficient":[218],"reduce":[220],"levels":[227],"would":[229],"be":[230],"seen":[231],"if":[232],"continued":[235],"therapy.":[237],"Reducing":[238],"treatment":[242],"may":[244],"decrease":[245],"burden":[247],"osteoporosis":[249],"places":[250],"both":[252],"care":[256],"systems.":[257]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}